OXYGENTA PHARMACEUTICAL
|
The Current P/S Ratio of OXYGENTA PHARMACEUTICAL is 1.75.
| Share Price | ₹63.9 | Aug 20,2026 |
| Market Cap | ₹236.3 Cr | |
| Sales-TTM | ₹134.8 Cr | TTM-Standalone Results |
| Price/Sales | 1.75x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of OXYGENTA PHARMACEUTICAL
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹236.3 Cr] as on Aug 20,2026
(/) Sales [ ₹134.8 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 1.75x ]
Thus, for OXYGENTA PHARMACEUTICAL , the investors are currently willing to pay '1.75 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of OXYGENTA PHARMACEUTICAL !
The chart below summarizes the trend in P/S Ratio of OXYGENTA PHARMACEUTICAL over the last five years.
Historical PS (Price/Sales) ratio chart of OXYGENTA PHARMACEUTICAL
PS Ratio Performance Analysis for OXYGENTA PHARMACEUTICAL
- OXYGENTA PHARMACEUTICAL 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 1.79x.
- OXYGENTA PHARMACEUTICAL 's operated at median p/e ratio of 1.68x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, OXYGENTA PHARMACEUTICAL 's p/e ratio peaked in Mar2025 at 2.69x.
- OXYGENTA PHARMACEUTICAL 's p/e ratio hit its five-year low in Mar2022 of 0.56x.
How does OXYGENTA PHARMACEUTICAL 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| OXYGENTA PHARMACEUTICAL | 134.8 | 1.75 | 236.3 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 59,910.5 | 7.61 | 456,114.0 |
| DIVIS LABORATORIES LTD | 11,230.0 | 20.30 | 227,958.0 |
| TORRENT PHARMACEUTICALS LTD | 15,723.0 | 12.08 | 189,990.0 |
| CIPLA LTD | 28,324.4 | 4.10 | 116,141.0 |
| DR REDDYS LABORATORIES LTD | 33,227.9 | 2.97 | 98,604.4 |
| MANKIND PHARMA LTD | 14,737.9 | 6.68 | 98,499.5 |
| LUPIN LTD | 29,966.6 | 3.36 | 100,733.0 |
| ZYDUS LIFESCIENCES LTD | 28,591.7 | 3.87 | 110,603.0 |
| AUROBINDO PHARMA LTD | 34,935.3 | 2.65 | 92,428.7 |
| LAURUS LABS LTD | 7,269.6 | 13.55 | 98,498.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs OXYGENTA PHARMACEUTICAL 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 1.75x |
| Max industry PS | 20.30x |
| Median industry PS | 4.10x |
| Average industry PS | 7.17x |
You may also like the below Video Courses